EPAM’s Fall and the Fund’s Bet

On a November day, the Securities and Exchange Commission unveiled a tale of shifting tides. Senvest, a New York-based titan of capital, had quietly bolstered its stake in EPAM, acquiring 524,798 shares to swell its holdings to 968,404-a quarter-end value of $146 million. This was no mere transaction; it was a wager on the resilience of a company that, despite its fall, still held promise in the eyes of the wealthy.




